Maternal serum hormone concentrations for prediction of adverse outcome in threatened miscarriage

Reproductive BioMedicine Online

Volumn 15, Issue 4, 2007, Pages 413-421

  Johns, Jema ^a   Muttukrishna, S ^a   Lygnos, M ^a   Groome, N ^b   Jauniaux, E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

Adverse outcome; HCG; Inhibin; Placenta; Threatened miscarriage

Indexed keywords

ACTIVIN A; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLISTATIN; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROGESTERONE;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DELIVERY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HORMONE DETERMINATION; HUMAN; IMMINENT ABORTION; INCIDENCE; LIVE BIRTH; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL BLOOD; OUTCOME ASSESSMENT; PILOT STUDY; PREDICTION; PREGNANCY OUTCOME; PREGNANCY TERMINATION; TEACHING HOSPITAL; UNITED KINGDOM; UTERUS BLEEDING;

EID: 35148901647     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60367-7     Document Type: Article

References (66)

1. Al-Azemi M, Ledger WL, Diejomaoh M et al. 2003 Measurement of inhibin A and inhibin pro-αC in early pregnancy and their role in the prediction of pregnancy outcome in patients with recurrent pregnancy loss. Fertility and Sterility 80, 1473-1479.
2. Al-Sebai MA, Diver M, Hiplin LJ 1996 The role of a single free beta-human chorionic gonadotrophin measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability. Human Reproduction 11, 881-888.
3. Ball RH, Ade CM, Schoenborn JA, Crane JP 1996 The clinical significance of ultrasonographically detected subchorionic haemorrhages. American Journal of Obstetrics and Gynecology 174, 996-1002.
4. Banerjee S, Aslam N, Woelfer B et al. 2001 Expectant management of early pregnancies of unknown location: a prospective evaluation of methods to predict spontaneous resolution of pregnancy. British Journal of Obstetrics and Gynaecology 108, 158-163.
5. Baztofin JH, Fielding WL, Friedman EA 1984 Effect of vaginal bleeding in early pregnancy outcome. Obstetrics and Gynecology 63, 515-518.
6. Bearfield C, Janniaux E, Groome N et al. 2005 The secretion and effect of inhibin A, activin A and follistatin on first-trimester trophoblasts in vitro. European Journal of Endocrinology 152, 909-916.
7. Bobrow CS, Holmes RP, Muttukrishna S et al. 2002 Maternal serum activin A, inhibin A and follistatin in pregnancies with appropriately grown and small for gestational age fetuses classified by umbilical artery Doppler. American Journal of Obstetrics and Gynecology 186, 283-287.
8. Choong S, Rombauts L, Ugoni A, Meagher S 2003 Ultrasound prediction of risk of spontaneous miscarriage in live embryos from assisted conception. Ultrasound in Obstetrics and Gynecology 22, 571-577.
9. De Biasio P, Canini S, Crovo A et al. 2003 Early vaginal bleeding and first-trimester markers for Down syndrome. Prenatal Diagnosis 23, 470-473.
10. Debieve F, Pampfer S, Thomas K 2000 Inhibin and activin production and subunit expression in human placental cells cultured in vitro. Molecular Human Reproduction 6, 743-749.
11. Dumps P, Meisser A, Pons D et al. 2002 Accuracy of single measurement of pregnancy associated plasma protein-A, human chorionic gonadotrophin and progesterone in the diagnosis of early pregnancy failure. European Journal of Obstetrics, Gynecology and Reproductive Biology 100, 174-180.
12. Elovitz MA, Baron J, Phillippe M 2001 The role of thrombin in pre-term parturition. Transactions of the Twenty-First Annual Meeting of the Society for Maternal-Fetal Medicine. American Journal of Obstetrics and Gynecology 185, 1059-1063.
13. Evans LW, Muttukrishna S, Groome N 1998 Development, validation and application of an ultra sensitive two-site enzyme immunoassay for human follistatin. Journal of Endocrinology, 156, 275-282.
14. Farrell T, Owen P 1996 The significance of extrachorionic membrane separation in threatened miscarriage. British Journal of Obstetrics and Gynaecology 103, 926-928.
15. Florio P, Luisi S, D'Antona D et al. 2004 Maternal serum inhibin A levels may predict pregnancy outcome in women with threatened abortion. Fertility and Sterility 81, 468-470.
16. Fowler PA, Evans LW, Groome NP et al. 1998 A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alpha C and follistatin during pregnancy. Human Reproduction 13, 3530-3536.
17. Greenwold N, Janniaux ER, Gulbis B et al. 2003 Relationship among maternal serum endocrinology, placental karyotype and intervillous circulation in early pregnancy failure. Fertility and Sterility 79, 1373.
18. Haddad B, Abirached F, Louis-Sylvestre C et al. 1999 Predictive value of early human chorionic gonadotrophin serum profiles for fetal growth retardation. Human Reproduction 14, 2872-2875.
19. Hahlin M, Sjoblom P, Lindblom B 1991 Combined use of progesterone and human chorionic gonadotrophin determinations for differential diagnosis of very early pregnancy. Fertility and Sterility 55, 492.
20. Hauzman E, Fedorcsak P, Klinga K et al. 2004 Use of serum inhibin A and human chorionic gonadotrophin measurements to predict the outcome of in vitro fertilisation pregnancies. Fertility and Sterility 81, 66-72.
21. Henderson D, Bennett P, Moore G 1992 Expression of human chorionic gonadotrophin alpha and beta subunits is depressed in trophoblast from pregnancies with early embryonic failure. Human Reproduction 7, 1474-1478.
22. Jaunianx E, Hempstock J, Greenwold N, Burton GJ 2003 Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. American Journal of Pathology 162, 115-125.
23. Johns J, Hyett J, Jaunianx E 2003 Obstetric outcome after threatened miscarriage with and without a hematoma on ultrasound. Obstetrics and Gynecology 102, 483-487.
24. Johnson MR, Riddle AF, Sharma V et al. 1993 Placental and ovarian hormones in anembryonic pregnancy. Human Reproduction 8, 115.
25. Jones CJ, Fox H 2005 An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta 1, 61-76.
26. Jouppila P 1985 Clinical consequences after ultrasonic diagnosis of intrauterine hematoma in threatened abortion. Journal of Clinical Ultrasound 13, 107-111.
27. Kozian DH, Ziche M, Augustin HG 1997 The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Laboratory Investigation 76, 267-276.
28. Lockwood GM, Ledger WL, Barlow DH et al. 1997 Measurement of inhibin and activin in early human pregnancy: demonstration of feto-placental origin and role in prediction of early pregnancy outcome. Biology of Reproduction 57, 1490-1494.
29. Lower AM, Yovich JL 1992 The value of serum levels of oestradiol, progesterone and β-human chorionic gonadotrophin in the prediction of early pregnancy loss. Human Reproduction 7, 711-717.
30. Luisi S, Florio P, D'Antona D et al. 2003 Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriages. European Journal of Endocrinology 148, 233-236
31. Makrydimas G, Sebire N, Lolis D et al. 2003 Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation. Ultrasound in Obstetrics and Gynecology 22, 368-372.
32. Mantoni M, Fog Pedersen J 1981 Intrauterine haematoma-an ultrasonic study of threatened abortion. British Journal of Obstetrics and Gynecology 88, 47-51.
33. Manuelpillai U, Schneider-Kolsky M, Dole A, Wallace EM 2001 Activin A and activin receptors in gestational tissue from preeclamptic pregnancies. Journal of Endocrinology 171, 57-64.
34. Mersol-Barg MS, Miller KF, Choi CM et al. 1990 Inhibin suppresses chorionic gonadotrophin in term but not first trimester placentas. Journal of Clinical Endocrinology and Metabolism 71, 1294-1298.
35. Mulik V, Bethel J, Bhal K 2004 A retrospective population-based study of primigravid women on the potential effect of threatened miscarriage on obstetric outcome. Journal of Obstetrics and Gynaecology 24, 249-253.
36. Muttukrishna S, Bearfield C, Johns J, Janniaux E 2004 Inhibin, activin, follistatin, activin receptors and β-glycan gene expression in the villous tissue of miscarriage patients. Molecular Human Reproduction 10, 793-798.
37. Muttukrishna S, Jauniaux E, Greenwold N et al. 2002 Levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Human Reproduction 17, 3072-3078.
38. Muttukrishna S, North RA, Morris J et al. 2000 Serum inhibin and activin A are elevated prior to the onset of pre-eclampsia. Human Reproduction 15, 1640-1645.
39. Muttukrishna S, Child TJ, Groome N-P, Ledger WL 1997a The source of circulating inhibin-A pro-alpha C containing inhibins and activin A in early pregnancy. Human Reproduction 12, 1089-1093.
40. Muttukrishna S, Knight PG, Groome NP et al. 1997b Inhibin A and activin A: new endocrine markers for pre-eclampisa? Lancet 349, 1285-1288.
41. Muttukrishna S, Fowler PA, George L et al. 1996 Changes in peripheral serum levels of total activin a during the human menstrual cycle and pregnancy. Journal of Clinical Endocrinology and Metabolism 81, 3328-3334.
42. Muttukrishna S, George L, Fowler PA et al. 1995 Measurement of serum concentrations of inhibin A (alpha-beta A dimer) during human pregnancy. Clinical Endocrinology 42, 391-397.
43. Muttukrishna S, Fowler PA, Groome NP et al. 1994 Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Human Reproduction 9, 1634-1642.
44. Ong CYT, Liao AW, Spencer K, Nicolaides K 2000a First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. British Journal of Obstetrics and Gynaecology 107, 1265-1270.
45. Ong CYT, Liao AW, Spencer K, Nicolaides K 2000b First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. British Journal of Obstetrics and Gynaecology 107, 1265-1270.
46. Peng C, Ohno T, Koh LY et al. 1999 Human ovary and placenta express messenger RNA for multiple activin receptors. Life Sciences 64, 983-994.
47. Petraglia F 1997 Inhibin, activin and follistatin in the human placenta - a new family of regulatory proteins. Placenta 18, 3-8.
48. Petraglia F, Aguzzoli L, Gallinelli A et al. 1995 Hypertension in pregnancy: changes in activin A maternal serum concentration. Placenta 16, 447-454.
49. Petraglia F, Garuti GC, Calza L et al., 1991 Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy. American Journal of Obstetrics and Gynecology 165, 750-758.
50. Petraglia F, Vaughan J, Vale W 1989 Inhibin and activin modulate the release of gonadotrophin-releasing hormone, human chorionic gonadotrophin and progesterone from human placental cells. Proceedings of the National Academy of Sciences U S A 86, 5114-5117.
51. Phipps MG, Hogan JW, Peipert JF et al. 2000 Progesterone, inhibin and hCG multiple marker strategy to differentiate viable from non-viable pregnancies. Obstetrics and Gynecology 95, 227-231.
52. Ruge S, Pedersen JF, Sorensen S, Lunge AP 1990 Can pregnancy associated plasma protein-A (PAPP-A) predict the outcome of pregnancy in women with threatened abortion and confirmed fetal viability. Acta Obstetricia et Gynecologica Scandinavica 69, 589-595.
53. Silver HM, Lambert-Messerlian GM, Diblasio AM et al. 2002 Mechanism of increased maternal serum total activin A and inhibin A in pre-eclampsia. Journal of the Society for Gynecological Investigation 9, 308-312.
54. Stabile I, Olajiide F, Chard T, Grudzinskas JG 1989 Maternal serum alpha-fetoprotein in anembryonic pregnancy. Human Reproduction 4, 204-205.
55. Steele GL, Currie WD, Yuen BH et al. 1993 Acute stimulation of chorionic gonadotrophin secretion by recombinant human activin A in first trimester human trophoblast. Endocrinology 133, 297-303.
56. Tong S, Marjono B, Mulvey S, Wallace EM 2004 Low levels of pregnancy associated plasma protein-A in asymptomatic women destined for miscarriage. Fertility and Sterility 82, 1468-1470.
57. Tongsong T, Srisomboon J, Wanapirak C et al. 1995 Pregnancy outcome of threatened abortion with demonstrable fetal cardiac activity: a cohort study. Journal of Obstetrics and Gynaecology Tokyo, 21, 331-335.
58. Treetampinich C, O'Connor AE, MacLachlan V et al. 2000 Maternal serum inhibin-A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome. Human Reproduction 15, 2028-2032.
59. Urbancsek J, Hauzman E, Fedorcsak P et al., 2002 Serum human chorionic gonadotrophin measurements may predict pregnancy outcome and multiple gestation after in vitro fertilisation. Fertility and Sterility 78, 540-542.
60. Wald N, Watt HC 1996 Serum markers for Down's syndrome in relation to number of previous births and maternal age. Prenatal Diagnosis 16, 699-703.
61. Wallace EM, Healy DL 1996 Inhibins and activins: roles in clinical practice. British Journal of Obstetrics and Gynaecology 103, 945-956.
62. Wallace EM, Marjono B, Tyzack K, Tong S 2004 First trimester levels of inhibins and activin A in normal and failing pregnancies. Clinical Endocrinology 60, 484-490.
63. Weiss JL, Malone FD, Vidaver J et al. 2004 Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study. American Journal of Obstetrics and Gynecology 190, 745-750.
64. Westergaard JG, Teisner B, Sinosich MJ et al. 1985 Does ultrasound examination render biochemical tests obsolete in the prediction of early pregnancy failure? British Journal of Obstetrics and Gynaecology 92, 77-83.
65. Yaron Y, Heifetz S, Ochshorn Y 2002a Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenatal Diagnosis 22, 778-782.
66. Yaron Y, Ochshorn Y, Heifetz S et al. 2002b First trimester maternal serum free human chorionic gonadotrophin as a predictor of adverse pregnancy outcome. Fetal Diagnosis and Therapy 17, 352-356.